Read + Share
Amedeo Smart
Independent Medical Education
Leung HW, Leung CO, Lau EY, Chung KPS, et al. EPHB2 activates beta-catenin to enhance cancer stem cell properties and drive sorafenib resistance in hepatocellular carcinoma. Cancer Res 2021 Apr 26. pii: 0008-5472.CAN-21-0184.PMID: 33903122
Email
LinkedIn
Facebook
Twitter
Privacy Policy